Medical Countermeasures U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC OutbreakGlobal Biodefense StaffJune 12, 2026
Medical Countermeasures CEPI Funds Three Bundibugyo Ebolavirus Vaccine Candidates, Including Oxford’s ChAdOx1-Based ApproachGlobal Biodefense StaffJune 1, 2026
Medical Countermeasures The Mpox Vaccine Works — But Its Immunity Fades Fast. A Third Dose May Help.Global Biodefense StaffMay 19, 2026
Why Moderna Won’t Share Rights to the COVID-19 Vaccine with the Government That Paid for Its Development Medical Countermeasures November 18, 2021 …
JPEO-CBRND Seeks Prototype Proposals for Vaccine Acceleration Program Contracts + Grants November 15, 2021 …
Birmingham Biotech and University of Birmingham Partner on Covid-19 Anti-viral Nasal Spray Industry News November 9, 2021 …
Nose Sprays, Needle-Free Patches, Durable Immunity: Towards the Next Generation of COVID Vaccines Medical Countermeasures November 8, 2021 …
Vaccination Offers Higher Protection Than Previous COVID-19 Infection Medical Countermeasures October 29, 2021 …
A Pediatrician Explains How Pfizer’s Covid-19 Vaccine for Ages 5 to 11 Was Tested for Safety and Efficacy Medical Countermeasures October 29, 2021 …
Rwanda and Senegal Will Host Africa’s First COVID-19 Vaccine Manufacturing Plants Industry News October 27, 2021 …
Ivermectin: Misuse Against COVID Risks Undermining Its Use for Other Diseases Medical Countermeasures October 27, 2021 …
Navigating New Federal Rules on ‘Mix-and-Match’ Vaccine Booster Shots Medical Countermeasures October 27, 2021 …
Data Shows Continued Vulnerability of Vaccinated Blood Cancer Patients to COVID-19 Medical Countermeasures October 23, 2021 …
How a BBQ Lighter Sparked a Breakthrough Idea on Vaccine Delivery Medical Countermeasures October 23, 2021 …
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines Contracts + Grants October 21, 2021 …
Moderna COVID Booster Study in Rhesus Macaques Shows Increased Antibody Response Medical Countermeasures October 21, 2021 …
“Resurrector” Drugs Have Potential to Rescue Aged AChE to Fight Nerve Agents CBRNE October 17, 2021 …
New Antiviral Compound Blocks SARS-CoV-2 From Entering Cells Medical Countermeasures October 13, 2021 …
MIT Researchers Make Progress on Antibiotic Resistance Under DTRA-JSTO Research Program Antimicrobial Resistance October 12, 2021 …
First-in-Class Nerve Agent Antidote Crosses Blood-Brain Barrier to Aid Central Nervous System CBRNE October 12, 2021 …
